News / 18 September 2025

EMBL Australia is pleased to announce the expansion of its Partner Laboratory Network Steering Committee, welcoming new senior representatives from leading research institutions across the country.

This strategic growth enhances the committee’s capacity to support national and international scientific collaboration, training and innovation – ensuring the Partner Laboratory Network (PLN) continues to deliver world-class research outcomes.

Joining our well-established team of renowned scientific leaders from PLN host institutes are Professor Lisa Butler, Professor Edwina McGlinn, Associate Professor Izzy Jayasinghe, Associate Professor Amee George, Professor Ryan Lister and Professor Denise Doolan.

 

LISA BUTLER (SAIGENCI)

Professor Lisa Butler is a leading cancer researcher at SAiGENCI and the University of Adelaide, and Director of the Solid Tumour Program at SAHMRI. Her work focuses on understanding the molecular drivers of prostate cancer progression and treatment resistance, with the goal of identifying new biomarkers and therapies. An advocate for translational research, she has held leadership roles with the Australian Prostate Cancer BioResource, the Prostate Cancer Foundation of Australia and the ANZUP Cancer Trials Group.

 

 

Edwina mcglinn (Monash university)

Professor Edwina McGlinn is a developmental biologist and EMBL Australia alumna, currently leading a research group at the Australian Regenerative Medicine Institute (ARMI), Monash University, where she also serves as Head of Research Excellence and Mentorship. Her internationally recognised research focuses on the gene networks that drive embryonic growth and identity, building on postdoctoral work at Harvard Medical School and a PhD at the University of Queensland.

 

 

izzy jayasinghe (UNSW)

Associate Professor Izzy Jayasinghe is a leading biophysicist based at UNSW Sydney, where she serves as Head of the Department of Molecular Medicine in the School of Biomedical Sciences. Her research combines advanced optical and nanotechnologies – particularly super-resolution microscopy – with biomedical cell biology to investigate the structural basis of nanoscale signalling within cells in health and in cardiac diseases.

 

 

amee george (ANU)

Associate Professor Amee George is a biomedical researcher at the Australian National University, where she leads a research program investigating cell growth pathways in disease, heads the ANU Centre for Therapeutic Discovery (ACTD), manages the National Therapeutic mRNA Platform and serves on Phenomics Australia’s Scientific Directors team. Her interdisciplinary work spans molecular and cell biology, pharmacology and translational medicine, with applications across a broad range of indications, including cancer and rare disorders.

 

 

ryan lister (Harry Perkins / UWA)

Professor Ryan Lister is a genomic researcher based at the University of Western Australia, where he leads the Genome Biology and Genetic Diseases Program at the Harry Perkins Institute of Medical Research. His research focuses on understanding gene regulation and genome function in health and disease, using pioneering high-throughput sequencing methodologies, advanced genomic technologies and computational approaches.

 

 

Denise doolan (institute for molecular bioscience at uq)

Professor Denise Doolan is a world-leading expert in malaria immunology, vaccinology and omics-based approaches for therapeutic and diagnostic development. She is Director of Research at the Institute for Molecular Bioscience (IMB) at the University of Queensland and was previously Acting Director of the Australian Institute for Tropical Health and Medicine (AITHM) at James Cook University. She serves on a number of executive and advisory boards, including the Federal Government’s Australian Medical Research Advisory Board.

 

 

More about the Steering Committee.

Back to News